Central Drug Standards Control Organisation

Exclusive: Nobody Approved India’s COVID-19 ‘Precautionary’ Doses

COVID: Govt Panel Recommends Phase 3 Trial of Covovax as Booster for Adults

COVID-19: Govt Panel Recommends EUA for Covovax, Corbevax and Molnupiravir

DCGI Okays Covaxin For Young Adults Aged 12-18 Years, With Some Conditions

Drug Given at Mohalla Clinics Caused Death of 3 Children, Govt Says

India Allows Serum Institute to Enrol 7-11 Year Olds in COVID Vaccine Trial

Cipla Gets DCGI Nod to Import Moderna’s Vaccine for India: Sources